Page last updated: 2024-08-21

dronabinol and Psychoses, Drug

dronabinol has been researched along with Psychoses, Drug in 86 studies

Research

Studies (86)

Timeframe	Studies, this research(%)	All Research%
pre-1990	18 (20.93)	18.7374
1990's	4 (4.65)	18.2507
2000's	27 (31.40)	29.6817
2010's	33 (38.37)	24.3611
2020's	4 (4.65)	2.80

Authors

Authors	Studies
Bogler, OD; Stall, NM; Zipursky, JS	1
Beck, K; Borgan, F; D'Souza, DC; Ganesh, S; Ginestet, CE; Hindley, G; Howes, OD; Kleinloog, D; McCutcheon, R; Radhakrishnan, R	1
Cortes-Briones, J; D'Souza, DC; Ganesh, S; Radhakrishnan, R; Ranganathan, M; Skosnik, PD	1
Denovan-Wright, EM; Garai, S; Greba, Q; Howland, JG; Laprairie, RB; McElroy, DL; Roebuck, AJ; Scott, GA; Thakur, GA	1
Connemann, BJ; Gahr, M; Hiemke, C; Schönfeldt-Lecuona, C	1
Fox, SH; Freitas, ME; Lang, AE; Udow, SJ	1
Allen, P; Atakan, Z; Bhattacharyya, S; Brammer, M; Giampietro, V; McGuire, PK; Nosarti, C; Sainsbury, T	1
Bhattacharyya, S; Brammer, M; Colizzi, M; Giampietro, V; McGuire, P; Williams, S	1
DiPrinzo, D; McAllister, R; Sethi, R	1
Curran, HV; Freeman, TP; Gardner, C; Hindocha, C; Morgan, CJA; Schafer, G	1
Carbonaro, S; DeFrancisco, DR; Galynker, II; Hurd, YL; Mann, CL; Parvez, L; Perkel, CA; Spriggs, S	1
Herman, MS; Rosenzweig, I; Vukadinovic, Z	1
Chan, WL; Dargan, PI; Hudson, S; Wood, DM	1
Baldacchino, A; Blair, H; Crome, IB; Hughes, Z; Kehoe, M; Teh, Y; Windeatt, S	1
Brunt, T; van Amsterdam, J; van den Brink, W	1
Degenhardt, L; Hall, W	1
Hamilton, I	1
Dunn, G; Evans, N; Freeman, D; Harrison, PJ; Lister, R; Morrison, PD; Murray, RM; Stumpenhorst, K; Tunbridge, EM	1
Gandal, M; Pierre, JM; Son, M	1
Busquets-Garcia, A; Chaouloff, F; Ferreira, G; Mackenbach, Y; Marsicano, G; Piazza, PV; Redon, B; Soria-Gómez, E; Vallée, M; Varilh, M	1
Costentin, J	1
di Forti, M; Luzi, S; Morrison, PD; Murray, RM; Powell, J	1
Kawohl, W; Rössler, W	1
Hall, W; Room, R	2
Kisely, S	2
Allen, P; Atakan, Z; Bhattacharyya, S; Borgwardt, SJ; Crippa, JA; Fusar-Poli, P; Martin-Santos, R; McGuire, PK; O'Carrol, C; Seal, M; Surguladze, SA; Zuardi, AW	1
Holt, DW; Kapur, S; Lee, TD; McKeown, DA; Morrison, PD; Murray, RM; Powell, JF; Zois, V	1
Allen, P; Atakan, Z; Bhattacharyya, S; Borgwardt, S; Crippa, JA; Fletcher, PC; Fusar-Poli, P; Giampietro, V; Martin-Santos, R; McGuire, P; Mechelli, A; Nosarti, C; O'Carroll, C; Seal, ML	1
Butt, A; Dazzan, P; Di Forti, M; Handley, R; Luzi, S; Marques, TR; Mondelli, V; Morgan, C; Murray, RM; Paparelli, A; Pariante, C; Powell, J; Russo, M; Stilo, SA; Wiffen, B	1
Dahl-Sørensen, R; Klinke, HB; Müller, IB; Steffenrud, S	1
Loga, S; Loga-Zec, S; Spremo, M	1
van Winkel, R	1
Bhattacharyya, S; Brenneisen, R; Ffytche, DH; Holt, D; Kapur, S; McGuire, P; Morrison, PD; Murray, RM; Nottage, J; Stone, JM; Sumich, A; Tunstall, N; Wilson, D	1
Gross, H	1
Curran, HV; Demarchi, C; Freeman, TP; Gardener, C; Lewis, S; Morgan, CJ; Ramoutar, A; Rupasinghe, I; Schafer, G; Swan, S; Tan, N; Warrington, P; Wingham, G	1
Heekeren, K	1
Braley, G; Carbuto, M; D'Souza, DC; Elander, J; Perry, E; Pittman, B; Radhakrishnan, R; Ranganathan, M; Sewell, RA	1
Atakan, Z; Bhattacharyya, S; Brammer, M; Collier, DA; Crippa, JA; Kambeitz, J; Martin-Santos, R; McGuire, PK; Prata, D; Williams, S	1
Ashton, JC	1
Arnold, JC; Boucher, AA; Karl, T	1
Allen, P; Atakan, Z; Bhattacharyya, S; Borgwardt, SJ; Crippa, JA; Fusar-Poli, P; Martín-Santos, R; McGuire, P; Rubia, K; Sallis, H; Seal, M; Stahl, D; Zuardi, AW	1
Morrison, PD; Stone, JM	1
Deiana, S	1
Evins, AE; Green, AI; Kane, JM; Murray, RM	1
Hambrecht, M	1
Ammerman, Y; Braley, G; Cooper, T; D'Souza, DC; Gueorguieva, R; Krystal, JH; MacDougall, L; Perry, E; Wu, YT	1
Appenzeller, M; Augsburger, M; Buclin, T; Favrat, B; Giroud, C; Mangin, P; Ménétrey, A; Pin, M; Rothuizen, LE	1
André, C; Aquino-Neto, FR; Bento, RM; Damasceno, LM; Jaber-Filho, JA	1
Drukker, M; Fananás, L; Henquet, C; Krabbendam, L; Papiol, S; Ramaekers, JG; Rosa, A; van Os, J	1
Emrich, HM; Gerth, CW; Haensel, A; Klosterkötter, J; Koethe, D; Leweke, FM; Neatby, MA; Schneider, U; Schultze-Lutter, F; Thies, M	1
Linszen, D; van Amelsvoort, T	1
Khiabani, HZ; Mørland, J	1
Gallinat, J; Juckel, G; Nadulski, T; Roser, P; Stadelmann, AM	1
Braley, G; Cooper, T; D'Souza, DC; Gueorguieva, R; Krystal, J; Perry, E; Ranganathan, M; Zimolo, Z	1
Castle, D	1
Henquet, C; Van Os, J	1
Curran, HV; Morgan, CJ	1
Curran, HV; Mason, OJ; Morgan, CJ; Stefanovic, A	1
Schneider, M	1
Koethe, D; Leweke, FM	1
Jones, RT	1
Negrete, JC	1
Bowers, MB; Druss, B; Imirowicz, R; Mazure, CM	1
Kleiner, D; Stosberg, K; Täschner, KL; Tossmann, HP; Wiesbeck, G	1
Assion, HJ; Heinemann, F	1
Stefanis, C	1
Jones, R	1
Gregg, JM; Moore, R; Raft, D; Small, EW; Toomey, TC	1
Cole, JO; Lukas, SE; Stoll, AL	1
Tunving, K	1
Ghodse, AH	1
Bech, P; Rafaelsen, L; Rafaelsen, OJ	1
Carranza-Acevedo, J	1
Edwards, G	1
Paton, WD	1
Anderson, RE; Davies, NH; Deardorff, CM; Melges, FT; Owen, CA; Tinklenberg, JR	1
Nahas, GG; Vourch, G	1
Chesher, G; Thomas, R	1
Retterstol, N	1
Fairbairn, JW; Hindmarch, I; Simic, S; Tylden, E	1
Herha, J	1
Brill, NQ; Hochman, JS	1

Reviews

19 review(s) available for dronabinol and Psychoses, Drug

Article	Year
Psychiatric symptoms caused by cannabis constituents: a systematic review and meta-analysis. The lancet. Psychiatry, 2020, Volume: 7, Issue:4 Topics: Administration, Inhalation; Cannabidiol; Dronabinol; Drug Combinations; Drug Interactions; Hallucinogens; Humans; Marijuana Smoking; Psychoses, Substance-Induced	2020
Psychosis-Relevant Effects of Intravenous Delta-9-Tetrahydrocannabinol: A Mega Analysis of Individual Participant-Data from Human Laboratory Studies. The international journal of neuropsychopharmacology, 2020, 12-03, Volume: 23, Issue:9 Topics: Adult; Cannabinoid Receptor Agonists; Dose-Response Relationship, Drug; Dronabinol; Female; Humans; Male; Psychoses, Substance-Induced; Randomized Controlled Trials as Topic	2020
Cannabis, psychosis and the thalamus: a theoretical review. Neuroscience and biobehavioral reviews, 2013, Volume: 37, Issue:4 Topics: Animals; Calcium Channels, T-Type; Cannabinoids; Cannabis; Cerebral Cortex; Dronabinol; Electroencephalography; Hallucinogens; Humans; Neural Pathways; Psychoses, Substance-Induced; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Thalamus	2013
Cannabis psychosis: examining the evidence for a distinctive psychopathology in a systematic and narrative review. The American journal on addictions, 2012, Volume: 21 Suppl 1 Topics: Dronabinol; Hallucinogens; Humans; Marijuana Smoking; Psychoses, Substance-Induced	2012
The adverse health effects of synthetic cannabinoids with emphasis on psychosis-like effects. Journal of psychopharmacology (Oxford, England), 2015, Volume: 29, Issue:3 Topics: Animals; Cannabidiol; Cannabinoid Receptor Agonists; Cannabinoids; Cannabis; Dronabinol; Humans; Psychoses, Substance-Induced	2015
[Neuropsychopharmacology of delta-9-tetrahydrocannabinol]. Annales pharmaceutiques francaises, 2008, Volume: 66, Issue:4 Topics: Anxiety; Cannabinoid Receptor Modulators; Cognition; Depression; Dronabinol; Humans; Marijuana Abuse; Marijuana Smoking; Nervous System; Psychoses, Substance-Induced; Psychotropic Drugs; Receptor, Cannabinoid, CB1; Schizophrenic Psychology	2008
What is the mechanism whereby cannabis use increases risk of psychosis? Neurotoxicity research, 2008, Volume: 14, Issue:2-3 Topics: Abnormalities, Drug-Induced; Cannabidiol; Cannabinoid Receptor Modulators; Dopamine; Dronabinol; Humans; Marijuana Smoking; Paranoid Disorders; Psychoses, Substance-Induced; Receptor, Cannabinoid, CB1; Risk Factors; Schizophrenia	2008
[Cannabis and Schizophrenia: new findings in an old debate]. Neuropsychiatrie : Klinik, Diagnostik, Therapie und Rehabilitation : Organ der Gesellschaft Osterreichischer Nervenarzte und Psychiater, 2008, Volume: 22, Issue:4 Topics: Causality; Comorbidity; Cross-Sectional Studies; Dronabinol; Humans; Incidence; Marijuana Abuse; Psychoses, Substance-Induced; Risk; Schizophrenia	2008
[Does cannabis use lead to schizophrenia?]. Praxis, 2011, Nov-02, Volume: 100, Issue:22 Topics: Brain; Cannabidiol; Causality; Comorbidity; Cross-Sectional Studies; Diagnosis, Dual (Psychiatry); Dopamine; Dronabinol; Humans; Marijuana Abuse; Neuropsychological Tests; Psychoses, Substance-Induced; Risk; Schizophrenia; Switzerland	2011
Synthetic cannabinoids as drugs of abuse. Current drug abuse reviews, 2012, Volume: 5, Issue:2 Topics: Affect; Anxiety; Cannabinoid Receptor Agonists; Cannabinoids; Cardiovascular Diseases; Dronabinol; Humans; Illicit Drugs; Marijuana Abuse; Molecular Structure; Psychoses, Substance-Induced; Seizures	2012
Cannabis and psychosis: an update on course and biological plausible mechanisms. Current opinion in psychiatry, 2007, Volume: 20, Issue:2 Topics: Brain; Causality; Cerebrovascular Circulation; Cognition Disorders; Comorbidity; Dopamine; Dronabinol; Humans; Marijuana Abuse; Memory Disorders; Neuropsychological Tests; Positron-Emission Tomography; Psychoses, Substance-Induced; Risk Factors; Tomography, Emission-Computed, Single-Photon	2007
[Cannabis and cannabinoids as drugs]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2007, Mar-01, Volume: 127, Issue:5 Topics: Cannabinoid Receptor Antagonists; Cannabinoids; Cannabis; Cognition Disorders; Dronabinol; Humans; Piperidines; Psychoses, Substance-Induced; Psychotropic Drugs; Pyrazoles; Receptors, Cannabinoid; Rimonabant; Risk Factors	2007
Puberty as a highly vulnerable developmental period for the consequences of cannabis exposure. Addiction biology, 2008, Volume: 13, Issue:2 Topics: Adolescent; Adult; Animals; Brain; Cannabinoid Receptor Modulators; Cannabinoids; Child; Cognition Disorders; Dronabinol; Drug Tolerance; Humans; Marijuana Abuse; Neurons; Neuropsychological Tests; Psychoses, Substance-Induced; Puberty; Receptor, Cannabinoid, CB1; Risk Factors; Substance-Related Disorders	2008
Cannabis and psychiatric disorders: it is not only addiction. Addiction biology, 2008, Volume: 13, Issue:2 Topics: Affect; Animals; Antipsychotic Agents; Anxiety Disorders; Bipolar Disorder; Brain; Cannabinoid Receptor Modulators; Cannabinoids; Cognition Disorders; Depressive Disorder, Major; Dronabinol; Drug Interactions; Humans; Marijuana Abuse; Mood Disorders; Psychoses, Substance-Induced; Receptor, Cannabinoid, CB1; Risk Factors; Schizophrenia; Signal Transduction	2008
Human effects. NIDA research monograph, 1977, Issue:14 Topics: Animals; Biotransformation; Brain; Cannabinoids; Cannabis; Cardiovascular System; Dronabinol; Drug Interactions; Drug Tolerance; Electroencephalography; Female; Humans; Immunity, Cellular; Lung; Lung Volume Measurements; Luteinizing Hormone; Male; Perception; Psychoses, Substance-Induced; Sexual Behavior; Testosterone	1977
Psychiatric effects of cannabis use. Acta psychiatrica Scandinavica, 1985, Volume: 72, Issue:3 Topics: Acute Disease; Adolescent; Adolescent Behavior; Adult; Anxiety; Cerebrovascular Circulation; Chronic Disease; Cognition; Depression; Dronabinol; Electroencephalography; Female; Humans; Male; Marijuana Abuse; Mental Disorders; Middle Aged; Motivation; Personality Disorders; Psychoses, Substance-Induced; Substance Withdrawal Syndrome	1985
Cannabis psychosis. British journal of addiction, 1986, Volume: 81, Issue:4 Topics: Dronabinol; Humans; Paranoid Disorders; Psychoses, Substance-Induced	1986
Cannabis: a psychopharmacological review. Danish medical bulletin, 1974, Volume: 21, Issue:3 Topics: Animals; Arousal; Cannabis; Cricetinae; Dose-Response Relationship, Drug; Dronabinol; Drug Tolerance; Emotions; Half-Life; Haplorhini; Humans; Mice; Perceptual Disorders; Phytotherapy; Psychoses, Substance-Induced; Rabbits; Substance-Related Disorders; Swine	1974
Cannabis and its problems. Proceedings of the Royal Society of Medicine, 1973, Volume: 66, Issue:7 Topics: Abnormalities, Drug-Induced; Animals; Behavior; Blood Pressure; Body Temperature; Cannabis; Cerebral Ventricles; Dronabinol; Drug Tolerance; Electroencephalography; Female; Heart Rate; Humans; Memory; Microsomes, Liver; Phytotherapy; Pregnancy; Psychoses, Substance-Induced; Solubility; Substance Withdrawal Syndrome; Substance-Related Disorders	1973

Trials

18 trial(s) available for dronabinol and Psychoses, Drug

Article	Year
Increased hippocampal engagement during learning as a marker of sensitivity to psychotomimetic effects of δ-9-THC. Psychological medicine, 2018, Volume: 48, Issue:16 Topics: Adult; Brain Mapping; Cross-Over Studies; Double-Blind Method; Dronabinol; Hallucinogens; Hippocampus; Humans; Magnetic Resonance Imaging; Male; Psychoses, Substance-Induced; Verbal Learning; Young Adult	2018
Modulation of acute effects of delta-9-tetrahydrocannabinol on psychotomimetic effects, cognition and brain function by previous cannabis exposure. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2018, Volume: 28, Issue:7 Topics: Adult; Brain; Cognition; Double-Blind Method; Dronabinol; Functional Neuroimaging; Humans; Magnetic Resonance Imaging; Male; Marijuana Smoking; Psychoses, Substance-Induced; Young Adult	2018
Individual and combined effects of acute delta-9-tetrahydrocannabinol and cannabidiol on psychotomimetic symptoms and memory function. Translational psychiatry, 2018, 09-05, Volume: 8, Issue:1 Topics: Administration, Inhalation; Brief Psychiatric Rating Scale; Cannabidiol; Cross-Over Studies; Double-Blind Method; Dronabinol; Drug Combinations; Drug Interactions; Female; Hallucinogens; Humans; Male; Marijuana Smoking; Memory; Psychoses, Substance-Induced; United Kingdom; Young Adult	2018
Genetic moderation of the effects of cannabis: catechol-O-methyltransferase (COMT) affects the impact of Δ9-tetrahydrocannabinol (THC) on working memory performance but not on the occurrence of psychotic experiences. Journal of psychopharmacology (Oxford, England), 2015, Volume: 29, Issue:11 Topics: Adult; Catechol O-Methyltransferase; Cognition; Double-Blind Method; Dronabinol; Female; Genotype; Humans; Male; Memory, Short-Term; Polymorphism, Genetic; Psychoses, Substance-Induced	2015
Distinct effects of {delta}9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing. Archives of general psychiatry, 2009, Volume: 66, Issue:1 Topics: Adult; Amygdala; Anxiety; Arousal; Brain; Cannabidiol; Double-Blind Method; Dronabinol; Emotions; Facial Expression; Fear; Frontal Lobe; Galvanic Skin Response; Gyrus Cinguli; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Oxygen; Parahippocampal Gyrus; Parietal Lobe; Pattern Recognition, Visual; Psychiatric Status Rating Scales; Psychoses, Substance-Induced; Psychotropic Drugs; Young Adult	2009
The acute effects of synthetic intravenous Delta9-tetrahydrocannabinol on psychosis, mood and cognitive functioning. Psychological medicine, 2009, Volume: 39, Issue:10 Topics: Adult; Affect; Arousal; Cognition; Double-Blind Method; Dronabinol; Humans; Injections, Intravenous; Male; Psychiatric Status Rating Scales; Psychological Tests; Psychoses, Substance-Induced	2009
Modulation of mediotemporal and ventrostriatal function in humans by Delta9-tetrahydrocannabinol: a neural basis for the effects of Cannabis sativa on learning and psychosis. Archives of general psychiatry, 2009, Volume: 66, Issue:4 Topics: Administration, Oral; Adult; Arousal; Attention; Cannabidiol; Cannabis; Corpus Striatum; Double-Blind Method; Dronabinol; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Mental Recall; Oxygen; Paired-Associate Learning; Parahippocampal Gyrus; Psychoses, Substance-Induced; Temporal Lobe	2009
Disruption of frontal θ coherence by Δ9-tetrahydrocannabinol is associated with positive psychotic symptoms. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2011, Volume: 36, Issue:4 Topics: Adult; Cross-Over Studies; Double-Blind Method; Dronabinol; Electroencephalography; Female; Frontal Lobe; Humans; Male; Middle Aged; Nerve Net; Psychoses, Substance-Induced; Theta Rhythm; Young Adult	2011
Naltrexone does not attenuate the effects of intravenous Δ9-tetrahydrocannabinol in healthy humans. The international journal of neuropsychopharmacology, 2012, Volume: 15, Issue:9 Topics: Adolescent; Adult; Attention; Behavior; Cognition; Cognition Disorders; Double-Blind Method; Dronabinol; Drug Interactions; Euphoria; Female; Hallucinogens; Humans; Inhibition, Psychological; Injections, Intravenous; Male; Marijuana Abuse; Memory; Mental Recall; Middle Aged; Naltrexone; Narcotic Antagonists; Orientation; Perception; Psychoses, Substance-Induced; Recognition, Psychology; Reward; Young Adult	2012
Preliminary report of biological basis of sensitivity to the effects of cannabis on psychosis: AKT1 and DAT1 genotype modulates the effects of δ-9-tetrahydrocannabinol on midbrain and striatal function. Molecular psychiatry, 2012, Volume: 17, Issue:12 Topics: Corpus Striatum; Dopamine Plasma Membrane Transport Proteins; Dronabinol; Genotype; Humans; Mesencephalon; Proto-Oncogene Proteins c-akt; Psychoses, Substance-Induced	2012
Cannabis affects people differently: inter-subject variation in the psychotogenic effects of Δ9-tetrahydrocannabinol: a functional magnetic resonance imaging study with healthy volunteers. Psychological medicine, 2013, Volume: 43, Issue:6 Topics: Adult; Brain; Cerebellum; Double-Blind Method; Dronabinol; Functional Neuroimaging; Hallucinogens; Healthy Volunteers; Humans; Magnetic Resonance Imaging; Male; Parahippocampal Gyrus; Psychoses, Substance-Induced; Temporal Lobe; Young Adult	2013
Synthetic delta-9-tetrahydrocannabinol elicits schizophrenia-like negative symptoms which are distinct from sedation. Human psychopharmacology, 2011, Volume: 26, Issue:1 Topics: Double-Blind Method; Dronabinol; Humans; Hypnotics and Sedatives; Injections, Intravenous; Male; Psychiatric Status Rating Scales; Psychoses, Substance-Induced; Psychotropic Drugs	2011
The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2004, Volume: 29, Issue:8 Topics: Adult; Anxiety; Arousal; Attention; Behavior; Cognition; Dose-Response Relationship, Drug; Double-Blind Method; Dronabinol; Female; Hallucinogens; Hemodynamics; Humans; Hydrocortisone; Injections, Intravenous; Male; Memory, Short-Term; Mental Recall; Panic; Prolactin; Psychiatric Status Rating Scales; Psychometrics; Psychoses, Substance-Induced; Speech; Verbal Learning	2004
An experimental study of catechol-o-methyltransferase Val158Met moderation of delta-9-tetrahydrocannabinol-induced effects on psychosis and cognition. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2006, Volume: 31, Issue:12 Topics: Adolescent; Adult; Amino Acid Sequence; Amino Acid Substitution; Brain; Catechol O-Methyltransferase; Cognition Disorders; Cross-Over Studies; DNA Mutational Analysis; Dopamine; Double-Blind Method; Dronabinol; Environmental Exposure; Female; Genetic Predisposition to Disease; Genetic Testing; Genotype; Humans; Male; Middle Aged; Placebos; Polymorphism, Single Nucleotide; Psychoses, Substance-Induced; Psychotic Disorders	2006
Acute effects of Delta9-tetrahydrocannabinol and standardized cannabis extract on the auditory evoked mismatch negativity. Schizophrenia research, 2007, Volume: 97, Issue:1-3 Topics: Acoustic Stimulation; Adult; Antipsychotic Agents; Auditory Cortex; Cannabidiol; Cannabinol; Cerebral Cortex; Cognition; Contingent Negative Variation; Cross-Over Studies; Double-Blind Method; Dronabinol; Drug Combinations; Electroencephalography; Evoked Potentials, Auditory; Female; Humans; Male; Prospective Studies; Psychoses, Substance-Induced; Signal Processing, Computer-Assisted; Stimulation, Chemical	2007
Blunted psychotomimetic and amnestic effects of delta-9-tetrahydrocannabinol in frequent users of cannabis. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2008, Volume: 33, Issue:10 Topics: Adolescent; Adult; Amnesia; Attention; Brain; Dose-Response Relationship, Drug; Double-Blind Method; Dronabinol; Drug Administration Schedule; Drug Tolerance; Female; Hallucinations; Hallucinogens; Humans; Hydrocortisone; Male; Marijuana Abuse; Middle Aged; Perceptual Disorders; Prolactin; Psychoses, Substance-Induced; Tachycardia; Young Adult	2008
Temporal disorganization and delusional-like ideation. Processes induced by hashish and alcohol. Archives of general psychiatry, 1974, Volume: 30, Issue:6 Topics: Adult; Alcoholic Intoxication; Cannabis; Clinical Trials as Topic; Consciousness; Delusions; Depersonalization; Dose-Response Relationship, Drug; Dronabinol; Emotions; Ethanol; Humans; Male; Placebos; Psychoses, Substance-Induced; Self Concept; Semantic Differential; Thinking	1974
Marijuana intoxication: pharmacological and psychological factors. Diseases of the nervous system, 1971, Volume: 32, Issue:10 Topics: Cannabis; Dronabinol; Humans; Perceptual Disorders; Phytotherapy; Placebos; Psychophysiologic Disorders; Psychoses, Substance-Induced; Substance-Related Disorders; United States	1971

Other Studies

49 other study(ies) available for dronabinol and Psychoses, Drug

Article	Year
Edible cannabis. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2020, 02-18, Volume: 192, Issue:7 Topics: Administration, Oral; Anxiety; Cannabis; Cardiovascular Diseases; Dose-Response Relationship, Drug; Dronabinol; Drug Labeling; Drug Packaging; Humans; Marijuana Use; Psychoses, Substance-Induced	2020
Antipsychotic potential of the type 1 cannabinoid receptor positive allosteric modulator GAT211: preclinical in vitro and in vivo studies. Psychopharmacology, 2021, Volume: 238, Issue:4 Topics: Animals; Antipsychotic Agents; Behavior, Animal; Cell Line; Dizocilpine Maleate; Dose-Response Relationship, Drug; Dronabinol; Excitatory Amino Acid Antagonists; Extracellular Signal-Regulated MAP Kinases; Indoles; Male; Motor Activity; Phosphorylation; Prepulse Inhibition; Psychoses, Substance-Induced; Rats; Rats, Long-Evans; Receptor, Cannabinoid, CB1	2021
First-Episode Psychosis Possibly due to Roxithromycin-Related Inhibition of Metabolization of Tetrahydrocannabinol. Journal of clinical psychopharmacology, 2017, Volume: 37, Issue:3 Topics: Anti-Bacterial Agents; Dronabinol; Humans; Male; Marijuana Use; Middle Aged; Psychoses, Substance-Induced; Roxithromycin	2017
Exacerbation of psychosis triggered by a synthetic cannabinoid in a 70-year-old woman with Parkinson disease. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2018, 01-15, Volume: 190, Issue:2 Topics: Aged; Cannabinoids; Delusions; Dronabinol; Dystonia; Female; Hallucinations; Humans; Parkinson Disease; Psychoses, Substance-Induced	2018
I Use "Wax" Because It Makes Me Calmer, But Now I Am Seeing 3D Images. The primary care companion for CNS disorders, 2018, Jun-21, Volume: 20, Issue:3 Topics: Adult; Anxiety; Butanes; Cannabis; Dronabinol; Female; Hallucinations; Hallucinogens; Humans; Plant Extracts; Plant Leaves; Psychoses, Substance-Induced	2018
The Relevance of Sex in the Association of Synthetic Cannabinoid Use With Psychosis and Agitation in an Inpatient Population. The Journal of clinical psychiatry, 2019, 07-02, Volume: 80, Issue:4 Topics: Adult; Cannabinoids; Dronabinol; Female; Humans; Inpatients; Male; Psychomotor Agitation; Psychoses, Substance-Induced; Psychotropic Drugs; Risk Factors; Sex Factors; Substance Abuse Detection; United States	2019
Acute psychosis associated with recreational use of benzofuran 6-(2-aminopropyl)benzofuran (6-APB) and cannabis. Journal of medical toxicology : official journal of the American College of Medical Toxicology, 2013, Volume: 9, Issue:3 Topics: Acute Disease; Adult; Akathisia, Drug-Induced; Benzofurans; Cannabinoids; Dronabinol; Emergency Medical Services; Humans; Illicit Drugs; Indoles; Internet; Male; Marijuana Abuse; Marijuana Smoking; Naphthalenes; Paranoid Behavior; Propylamines; Psychoses, Substance-Induced; Psychotropic Drugs; Self-Injurious Behavior; Severity of Illness Index; Substance Abuse Detection; Young Adult	2013
High potency cannabis: a risk factor for dependence, poor psychosocial outcomes, and psychosis. BMJ (Clinical research ed.), 2015, Mar-04, Volume: 350 Topics: Cannabidiol; Cannabis; Causality; Dronabinol; Humans; Marijuana Abuse; Psychoses, Substance-Induced; Risk Factors; Schizophrenia; Schizophrenic Psychology	2015
Need for a comprehensive national survey of cannabis use. BMJ (Clinical research ed.), 2015, Mar-30, Volume: 350 Topics: Cannabidiol; Cannabis; Dronabinol; Humans; Marijuana Abuse; Psychoses, Substance-Induced; Schizophrenia; Schizophrenic Psychology	2015
Cannabis-induced psychosis associated with high potency "wax dabs". Schizophrenia research, 2016, Volume: 172, Issue:1-3 Topics: Adolescent; Adult; Cannabis; Diagnosis, Differential; Dronabinol; Follow-Up Studies; Humans; Illicit Drugs; Male; Marijuana Abuse; Plant Extracts; Psychoses, Substance-Induced	2016
Pregnenolone blocks cannabinoid-induced acute psychotic-like states in mice. Molecular psychiatry, 2017, Volume: 22, Issue:11 Topics: Animals; Brain; Cannabinoid Receptor Antagonists; Cannabinoids; Cannabis; Dronabinol; Male; Mental Disorders; Mice; Mice, Inbred C57BL; Pregnenolone; Psychoses, Substance-Induced; Receptor, Cannabinoid, CB1	2017
Should we recriminalize cannabis use? The case against. Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2008, Volume: 53, Issue:12 Topics: Canada; Causality; Dose-Response Relationship, Drug; Dronabinol; Drug and Narcotic Control; Humans; Illicit Drugs; Marijuana Abuse; Psychoses, Substance-Induced; Public Policy; Young Adult	2008
The case for policy reform in cannabis control. Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2008, Volume: 53, Issue:12 Topics: Canada; Causality; Dronabinol; Drug and Narcotic Control; Humans; Illicit Drugs; Marijuana Abuse; Psychoses, Substance-Induced; Public Policy; Young Adult	2008
Obstacles to a regulated cannabis market. Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2008, Volume: 53, Issue:12 Topics: Canada; Dronabinol; Drug and Narcotic Control; Humans; Illicit Drugs; Psychoses, Substance-Induced; Public Policy; Risk Factors; Young Adult	2008
Applying the lessons of tobacco and alcohol control to cannabis. Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2008, Volume: 53, Issue:12 Topics: Alcohol Drinking; Canada; Dronabinol; Drug and Narcotic Control; Ethanol; Humans; Illicit Drugs; Marijuana Abuse; Nicotiana; Psychoses, Substance-Induced; Risk Factors; Smoking; Smoking Prevention	2008
High-potency cannabis and the risk of psychosis. The British journal of psychiatry : the journal of mental science, 2009, Volume: 195, Issue:6 Topics: Adolescent; Adult; Age Factors; Aged; Cannabis; Case-Control Studies; Dronabinol; Female; Humans; London; Male; Marijuana Smoking; Middle Aged; Psychoses, Substance-Induced; Risk Factors; Young Adult	2009
Two cases of lysergamide intoxication by ingestion of seeds from Hawaiian Baby Woodrose. Forensic science international, 2010, Apr-15, Volume: 197, Issue:1-3 Topics: Accidental Falls; Adult; Central Nervous System Depressants; Chromatography, High Pressure Liquid; Dronabinol; Ethanol; Forensic Toxicology; Half-Life; Hallucinogens; Humans; Lysergic Acid Diethylamide; Male; Marijuana Smoking; Mass Spectrometry; Multiple Trauma; Psychoses, Substance-Induced; Seeds; Solid Phase Extraction; Vitreous Body	2010
Medical marijuana and the mind. More is known about the psychiatric risks than the benefits. The Harvard mental health letter, 2010, Volume: 26, Issue:10 Topics: Administration, Inhalation; Administration, Oral; Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Health Knowledge, Attitudes, Practice; Humans; Marijuana Smoking; Nausea; Pain; Phytotherapy; Plant Preparations; Psychoses, Substance-Induced; United States	2010
Cannabis and psychiatric disorders. Psychiatria Danubina, 2010, Volume: 22, Issue:2 Topics: Accidents, Traffic; Adolescent; Bosnia and Herzegovina; Cross-Sectional Studies; Delusions; Depressive Disorder; Dronabinol; Humans; Marijuana Abuse; Panic Disorder; Psychoses, Substance-Induced; Risk Factors; Suicide	2010
Evidence that familial liability for psychosis is expressed as differential sensitivity to cannabis: an analysis of patient-sibling and sibling-control pairs. Archives of general psychiatry, 2011, Volume: 68, Issue:2 Topics: Adolescent; Adult; Belgium; Case-Control Studies; Comorbidity; Cross-Sectional Studies; Dronabinol; Female; Genetic Predisposition to Disease; Humans; Male; Marijuana Abuse; Middle Aged; Netherlands; Phenotype; Psychiatric Status Rating Scales; Psychoses, Substance-Induced; Psychotic Disorders; Risk Assessment; Schizotypal Personality Disorder; Siblings; Young Adult	2011
Family-based analysis of genetic variation underlying psychosis-inducing effects of cannabis: sibling analysis and proband follow-up. Archives of general psychiatry, 2011, Volume: 68, Issue:2 Topics: Adolescent; Adult; Belgium; Case-Control Studies; Dronabinol; Female; Follow-Up Studies; Gene Expression Regulation; Genetic Association Studies; Genetic Predisposition to Disease; Genetic Variation; Genotype; Humans; Male; Marijuana Abuse; Middle Aged; Netherlands; Polymorphism, Single Nucleotide; Psychiatric Status Rating Scales; Psychoses, Substance-Induced; Risk Factors; Schizotypal Personality Disorder; Siblings; Young Adult	2011
[Cannabis medicinal drugs. "Psychedelics" by prescription?]. MMW Fortschritte der Medizin, 2010, Nov-11, Volume: 152, Issue:45 Topics: Cannabidiol; Cannabis; Dronabinol; Drug Approval; Drug Combinations; Germany; Humans; Multiple Sclerosis; Muscle Spasticity; Pain; Palliative Care; Phytotherapy; Plant Extracts; Psychoses, Substance-Induced	2010
Sub-chronic impact of cannabinoids in street cannabis on cognition, psychotic-like symptoms and psychological well-being. Psychological medicine, 2012, Volume: 42, Issue:2 Topics: Adolescent; Adult; Anxiety; Cannabidiol; Cognition Disorders; Depression; Dronabinol; Female; Hair; Humans; Illicit Drugs; Male; Marijuana Smoking; Memory; Psychoses, Substance-Induced; Schizotypal Personality Disorder; Young Adult	2012
The yin and yang of cannabis-induced psychosis: the actions of Δ(9)-tetrahydrocannabinol and cannabidiol in rodent models of schizophrenia. Current pharmaceutical design, 2012, Volume: 18, Issue:32 Topics: Animals; Animals, Newborn; Cannabidiol; Disease Models, Animal; Dronabinol; Humans; Marijuana Abuse; Mice; Psychoses, Substance-Induced; Rats; Schizophrenia	2012
Medical use of cannabis. Cannabidiol: a new light for schizophrenia? Drug testing and analysis, 2013, Volume: 5, Issue:1 Topics: Animals; Antipsychotic Agents; Cannabidiol; Cannabis; Dronabinol; Humans; Marijuana Abuse; Psychoses, Substance-Induced; Schizophrenia; Schizophrenic Psychology	2013
The effect of marijuana use on the risk for schizophrenia. The Journal of clinical psychiatry, 2012, Volume: 73, Issue:11 Topics: Adolescent; Adult; Age of Onset; Alcohol Drinking; Cannabis; Causality; Child; Child, Preschool; Comorbidity; Dose-Response Relationship, Drug; Dronabinol; Female; Gene-Environment Interaction; Genetic Predisposition to Disease; Humans; Infant; Infant, Newborn; Marijuana Abuse; Marijuana Smoking; Pregnancy; Psychoses, Substance-Induced; Recurrence; Risk; Schizophrenia; Schizophrenic Psychology; Social Facilitation; Telecommunications; United States; Young Adult	2012
[Brave new world: cannabis for all? Some psychiatric remarks]. Psychiatrische Praxis, 2003, Volume: 30, Issue:4 Topics: Cannabis; Dronabinol; Drug and Narcotic Control; Germany; Hallucinogens; Humans; Marijuana Abuse; Psychoses, Substance-Induced; Psychotropic Drugs; Risk Factors	2003
Two cases of "cannabis acute psychosis" following the administration of oral cannabis. BMC psychiatry, 2005, Apr-01, Volume: 5 Topics: Acute Disease; Administration, Oral; Adult; Depersonalization; Dronabinol; Hallucinogens; Humans; Male; Marijuana Abuse; Marijuana Smoking; Paranoid Disorders; Psychoses, Substance-Induced	2005
Delirium following ingestion of marijuana present in chocolate cookies. CNS spectrums, 2006, Volume: 11, Issue:4 Topics: Adult; Cacao; Cannabis; Delirium; Diagnosis, Differential; Dronabinol; Food Contamination; Humans; Male; Metabolic Clearance Rate; Psychoses, Substance-Induced	2006
Disturbances of visual information processing in early states of psychosis and experimental delta-9-tetrahydrocannabinol altered states of consciousness. Schizophrenia research, 2006, Volume: 88, Issue:1-3 Topics: Acute Disease; Adolescent; Adult; Brief Psychiatric Rating Scale; Consciousness Disorders; Depth Perception; Dronabinol; Female; Hallucinogens; Humans; Male; Perceptual Disorders; Psychometrics; Psychoses, Substance-Induced; Schizophrenia, Paranoid; Severity of Illness Index; Vision, Binocular; Visual Perception	2006
Drawing conclusions about cannabis and psychosis. Psychological medicine, 2008, Volume: 38, Issue:3 Topics: Dronabinol; Humans; Marijuana Abuse; Psychiatric Status Rating Scales; Psychoses, Substance-Induced; Schizophrenia; Schizophrenic Psychology	2008
The coherence of the evidence linking cannabis with psychosis. Psychological medicine, 2008, Volume: 38, Issue:3 Topics: Comorbidity; Disease Susceptibility; Dronabinol; Humans; Marijuana Abuse; Psychoses, Substance-Induced; Risk Factors; Schizophrenia	2008
Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis. The British journal of psychiatry : the journal of mental science, 2008, Volume: 192, Issue:4 Topics: Adult; Analysis of Variance; Cannabidiol; Delusions; Dronabinol; Female; Hair; Humans; Male; Marijuana Abuse; Predictive Value of Tests; Psychoses, Substance-Induced	2008
The psychotomimetic states inventory (PSI): measuring psychotic-type experiences from ketamine and cannabis. Schizophrenia research, 2008, Volume: 103, Issue:1-3 Topics: Adolescent; Adult; Affective Symptoms; Anesthetics, Dissociative; Bipolar Disorder; Cognition Disorders; Delusions; Dronabinol; Female; Humans; Infusions, Intravenous; Ketamine; Marijuana Abuse; Paranoid Disorders; Perceptual Distortion; Personality Inventory; Psychoses, Substance-Induced; Substance Abuse Detection; Substance-Related Disorders	2008
Marijuana. Health and treatment issues. The Psychiatric clinics of North America, 1984, Volume: 7, Issue:4 Topics: Brain; Cannabidiol; Cannabinoids; Cardiovascular System; Digestive System; Dronabinol; Drug Interactions; Humans; Immune System; Lung; Marijuana Abuse; Motivation; Paraquat; Psychoses, Substance-Induced; Reproduction	1984
[Effect of cannabis use on health]. Acta psiquiatrica y psicologica de America latina, 1983, Volume: 29, Issue:4 Topics: Animals; Cannabinoids; Dronabinol; Female; Gastrointestinal Motility; Gonads; Heart Rate; Humans; Male; Marijuana Abuse; Memory, Short-Term; Pregnancy; Pregnancy Complications; Psychomotor Performance; Psychoses, Substance-Induced; Respiratory System; Substance-Related Disorders	1983
Autonomous psychosis following psychotogenic substance abuse. Biological psychiatry, 1995, Jan-15, Volume: 37, Issue:2 Topics: Cocaine; Dronabinol; Female; Humans; Lysergic Acid Diethylamide; Male; Middle Aged; Psychoses, Substance-Induced; Psychotropic Drugs; Recurrence; Risk Factors; Schizophrenia	1995
[Sequelae of cannabis use--results of a survey of experts on traffic accidents and "echopsychoses" (flash-back)]. Versicherungsmedizin, 1994, Feb-01, Volume: 46, Issue:1 Topics: Accidents, Traffic; Cannabinoids; Dronabinol; Expert Testimony; Germany; Humans; Liability, Legal; Marijuana Abuse; Psychoses, Substance-Induced; Reaction Time; Risk Factors	1994
[Psychiatric disorders after a single 3,4-methylenedioxyethamphetamine (MDE, "Eve") and tetrahydrocannabinol (cannabis) use]. Psychiatrische Praxis, 1996, Volume: 23, Issue:6 Topics: 3,4-Methylenedioxyamphetamine; Adult; Designer Drugs; Dronabinol; Drug Synergism; Female; Humans; Psychoses, Substance-Induced	1996
Biological aspects of cannabis use. NIDA research monograph, 1978, Issue:19 Topics: Adolescent; Adult; Blood Pressure; Brain; Cannabis; Cell Nucleus; Dronabinol; Electroencephalography; Female; Heart Rate; Histones; Humans; Lymphocytes; Male; Middle Aged; Motivation; Neurotransmitter Agents; Neutrophils; Psychological Tests; Psychoses, Substance-Induced; Spermatozoa; Substance Withdrawal Syndrome; Substance-Related Disorders	1978
Emotional response to intravenous delta9tetrahydrocannabinol during oral surgery. Journal of oral surgery (American Dental Association : 1965), 1976, Volume: 34, Issue:4 Topics: Adolescent; Adult; Anxiety; Cannabis; Diazepam; Dronabinol; Emotions; Hippocampus; Humans; Injections, Intravenous; Male; Mouth; Pain; Placebos; Psychological Tests; Psychoses, Substance-Induced; Retrospective Studies; Septum Pellucidum; Time Factors	1976
A case of mania as a result of fluoxetine-marijuana interaction. The Journal of clinical psychiatry, 1991, Volume: 52, Issue:6 Topics: Adult; Bipolar Disorder; Dronabinol; Drug Interactions; Female; Fluoxetine; Humans; Marijuana Smoking; Psychoses, Substance-Induced	1991
[Psychodysleptic effects of cannabis]. Archivos de investigacion medica, 1974, Volume: 5 SUPPL 1 Topics: Brain; Cannabis; Dronabinol; Drug Evaluation; Hallucinations; Humans; Psychoses, Substance-Induced; Substance-Related Disorders	1974
Cannabis and the criteria for legalisation of a currently prohibited recreational drug: groundwork for a debate. Acta psychiatrica Scandinavica. Supplementum, 1974, Volume: 251 Topics: Abnormalities, Drug-Induced; Accidents, Traffic; Animals; Brain Damage, Chronic; Cannabis; Carcinogens; Central Nervous System; Crime; Dronabinol; Drug and Narcotic Control; Drug Evaluation; Drug Evaluation, Preclinical; Humans; Legislation, Drug; Mutagens; Personality Disorders; Phytotherapy; Psychoses, Substance-Induced; Rabbits; Rats; Substance-Related Disorders; United Kingdom	1974
[Toxicity of Indian hemp]. La Nouvelle presse medicale, 1973, Jan-20, Volume: 2, Issue:3 Topics: Abnormalities, Drug-Induced; Administration, Oral; Animals; Atrophy; Brain; Cannabis; Cardiovascular System; Dose-Response Relationship, Drug; Dronabinol; Drug Interactions; Female; Humans; Injections, Intraperitoneal; Injections, Subcutaneous; Liver; Lung; Male; Pregnancy; Psychoses, Substance-Induced; Rabbits; Rats; Substance Withdrawal Syndrome; Substance-Related Disorders	1973
The pharmacology of marihuana. The Medical journal of Australia, 1973, Aug-04, Volume: 2, Issue:5 Topics: Animals; Anxiety; Australia; Blood Pressure; Cannabis; Consciousness; Dose-Response Relationship, Drug; Dronabinol; Drug and Narcotic Control; Drug Tolerance; Greece; Hallucinations; Heart Rate; Humans; Jamaica; Mental Processes; Motivation; Placebos; Psychoses, Substance-Induced; Substance-Related Disorders; Syndrome; United States	1973
[Are cannabis substances dangerous?]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 1973, Sep-10, Volume: 93, Issue:25 Topics: Cannabis; Dose-Response Relationship, Drug; Dronabinol; Heart Rate; Humans; Perceptual Disorders; Psychoses, Substance-Induced; Stimulation, Chemical; Substance-Related Disorders; Time Factors	1973
Cannabinoid content of some English reefers. Nature, 1974, May-17, Volume: 249, Issue:454 Topics: Cannabis; Depersonalization; Depression; Dose-Response Relationship, Drug; Dronabinol; England; Humans; Paranoid Disorders; Psychoses, Substance-Induced; Remission, Spontaneous; Substance-Related Disorders	1974
[Hashish and marihuana. A review]. Die Naturwissenschaften, 1974, Volume: 61, Issue:2 Topics: Cannabis; Cognition; Depersonalization; Dose-Response Relationship, Drug; Dronabinol; Emotions; Hallucinations; Humans; Motivation; Psychoses, Substance-Induced; Self Concept; Sensation; Sleep; Stimulation, Chemical; Substance-Related Disorders	1974